|
105 Companies |
|
193 Products |
|
193 Products |
|
133 Mechanisms of Action |
|
26 Trials |
|
4426 News |
|
| «12345678910111213...8990» |
- || Trial completion date: DESTINY TRIAL (Inspiron x Biomatrix) (clinicaltrials.gov) - Apr 18, 2018
P4, N=170, Active, not recruiting, Sponsor: Scitech Produtos Medicos Ltda
Trial completion date: Jan 2018 --> Jan 2019
- | Enrollment open, Trial completion date, Trial primary completion date: Stavanger UncomPlicatEd Elective PCI Same DaY Discharge Study (SPEEDY Study) (clinicaltrials.gov) - Apr 18, 2018
P=N/A, N=151, Recruiting, Sponsor: Helse Stavanger HF
Trial completion date: Jan 2018 --> Jan 2019 Not yet recruiting --> Recruiting | Trial completion date: May 2016 --> Dec 2020 | Trial primary completion date: May 2016 --> Dec 2019
- | Enrollment change, Trial withdrawal: Predictors of Coronary Artery Calcium Progression in Adults With a Prior Zero Coronary Artery Calcium Score (clinicaltrials.gov) - Apr 18, 2018
P=N/A, N=0, Withdrawn, Sponsor: San Antonio Military Medical Center
Not yet recruiting --> Recruiting | Trial completion date: May 2016 --> Dec 2020 | Trial primary completion date: May 2016 --> Dec 2019 N=1000 --> 0 | Not yet recruiting --> Withdrawn
- | Trial completion, Surgery: Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=31390, Completed, Sponsor: Johns Hopkins University
N=1000 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed
- | Trial completion, Trial primary completion date: RISCAID Study: Remote ISchemic Conditioning for Angiopathy In Diabetes (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=36, Completed, Sponsor: Steno Diabetes Center
Recruiting --> Completed Not yet recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jul 2017
- ||| Trial completion: MeriT-II: An Evaluation of BioMime (clinicaltrials.gov) - Apr 11, 2018
P=N/A, N=250, Completed, Sponsor: Meril Life Sciences Pvt. Ltd.
Not yet recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jul 2017 Active, not recruiting --> Completed
- ||| Trial completion, Enrollment change: MIOP/TRAPS: The Impact of Opioids in Coronary Heart Disease (clinicaltrials.gov) - Apr 11, 2018
P=N/A, N=750, Completed, Sponsor: Ruhr University of Bochum
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=502 --> 750
- | Trial completion, Phase classification, Trial primary completion date: Detecting and Addressing Preclinical Disability (clinicaltrials.gov) - Apr 9, 2018
P, N=148, Completed, Sponsor: McMaster University
Active, not recruiting --> Completed | N=502 --> 750 Active, not recruiting --> Completed | Phase classification: PN/A --> P | Trial primary completion date: Dec 2016 --> Jun 2017
- | Enrollment open, Trial completion date, Trial primary completion date: The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER (clinicaltrials.gov) - Apr 9, 2018
P=N/A, N=500, Recruiting, Sponsor: Queen's University
Active, not recruiting --> Completed | Phase classification: PN/A --> P | Trial primary completion date: Dec 2016 --> Jun 2017 Not yet recruiting --> Recruiting | Trial completion date: Jan 2018 --> Jan 2019 | Trial primary completion date: Nov 2017 --> Nov 2018
- | Hygroton (chlortalidone) / Alliance, NN1213 / Novo Nordisk
Phase classification: Genetics of Hypertension Associated Treatments (GenHAT) (clinicaltrials.gov) - Apr 6, 2018
P, N=37939, Completed, Sponsor: Donna Arnett, 257-5678
Not yet recruiting --> Recruiting | Trial completion date: Jan 2018 --> Jan 2019 | Trial primary completion date: Nov 2017 --> Nov 2018 Phase classification: P=N/A --> P
- | Savaysa (edoxaban) / Daiichi Sankyo
Trial completion: EDOX-APT: Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel (clinicaltrials.gov) - Apr 6, 2018
P4, N=80, Completed, Sponsor: University of Florida
Phase classification: P=N/A --> P Active, not recruiting --> Completed
- | Trial completion, Phase classification, Enrollment change: Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis (clinicaltrials.gov) - Apr 6, 2018
P, N=177, Completed, Sponsor: Ohio State University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 177
- | Phase classification: Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants (clinicaltrials.gov) - Apr 6, 2018
P, N=30, Completed, Sponsor: National Human Genome Research Institute (NHGRI)
Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 177 Phase classification: P=N/A --> P
- ||||||| Resolute ZES (zotarolimus-eluting stent) / Medtronic
Trial completion, Phase classification, Trial completion date, Real-world evidence, Real-world: R-C Registry: RESOLUTE China Registry: (clinicaltrials.gov) - Apr 6, 2018
P, N=1800, Completed, Sponsor: Medtronic Vascular
Phase classification: P=N/A --> P Active, not recruiting --> Completed | Phase classification: PN/A --> P | Trial completion date: Jul 2018 --> Dec 2017
- | Phase classification, Enrollment change: Age-Related Changes in Body Composition (clinicaltrials.gov) - Apr 6, 2018
P, N=24, Terminated, Sponsor: National Institute on Aging (NIA)
Active, not recruiting --> Completed | Phase classification: PN/A --> P | Trial completion date: Jul 2018 --> Dec 2017 Phase classification: P=N/A --> P | N=350 --> 24
- Phase classification: meriT-1: Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions (clinicaltrials.gov) - Apr 6, 2018
P=N/A, N=30, Completed, Sponsor: Meril Life Sciences Pvt. Ltd.
Phase classification: P=N/A --> P | N=350 --> 24 Phase classification: P4 --> P=N/A
- | Phase classification: Cardiovascular Disease Protection Tissue (clinicaltrials.gov) - Apr 5, 2018
P, N=180, Recruiting, Sponsor: University of Florida
Phase classification: P4 --> P=N/A Phase classification: P=N/A --> P
- || metformin / Generic mfg.
Phase classification: MET Study: Understanding the Effect of Metformin on Corus CAD (or ASGES) (clinicaltrials.gov) - Mar 31, 2018
P, N=37, Completed, Sponsor: CardioDx
Phase classification: P=N/A --> P Phase classification: P=N/A --> P
- || Phase classification: CU-PCP: Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making (clinicaltrials.gov) - Mar 31, 2018
P, N=0, Withdrawn, Sponsor: CardioDx
Phase classification: P=N/A --> P Phase classification: P=N/A --> P
- | Trial completion: Zilver Flex Post-Market Study in Japan (clinicaltrials.gov) - Mar 31, 2018
P=N/A, N=239, Completed, Sponsor: Cook Group Incorporated
Phase classification: P=N/A --> P Active, not recruiting --> Completed
- | Trial completion, Phase classification, Trial primary completion date: Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting (clinicaltrials.gov) - Mar 26, 2018
P=N/A, N=144, Completed, Sponsor: University Hospital Ostrava
Active, not recruiting --> Completed Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: Jun 2017 --> Sep 2017
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion: Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla) (clinicaltrials.gov) - Mar 23, 2018
P1, N=333, Completed, Sponsor: Cedars-Sinai Medical Center
Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: Jun 2017 --> Sep 2017 Recruiting --> Completed
- | Trial completion, Adherence: ISLAND: Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction (clinicaltrials.gov) - Mar 23, 2018
P=N/A, N=2742, Completed, Sponsor: Women's College Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date, Surgery: Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass (clinicaltrials.gov) - Mar 22, 2018
P2, N=126, Completed, Sponsor: University of Alberta
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Mar 2018 | Trial primary completion date: Oct 2017 --> Mar 2018
- | Trial termination: Outcomes of Femoro-popliteal Disease After Stent Deployment Under Intravascular Ultrasound Guidance (clinicaltrials.gov) - Mar 21, 2018
P=N/A, N=8, Terminated, Sponsor: Texas Tech University Health Sciences Center
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Mar 2018 | Trial primary completion date: Oct 2017 --> Mar 2018 Active, not recruiting --> Terminated; PI left institution--only 8 subjects were enrolled.
- | Trial completion: Coronary CT Angiography Using a Novel 3rd Generation Dual-Source CT System (clinicaltrials.gov) - Mar 21, 2018
P=N/A, N=46, Completed, Sponsor: U. Joseph Schoepf, MD
Active, not recruiting --> Terminated; PI left institution--only 8 subjects were enrolled. Suspended --> Completed
- | Trial termination: C1q/TNF-related Proteins in Coronary Artery Disease (clinicaltrials.gov) - Mar 20, 2018
P=N/A, N=362, Terminated, Sponsor: Korea University
Suspended --> Completed Recruiting --> Terminated; Study subjects were not enrolled.
- | Enrollment change, Trial withdrawal: SENS-FP: Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease (clinicaltrials.gov) - Mar 15, 2018
P=N/A, N=0, Withdrawn, Sponsor: Korea University Guro Hospital
Recruiting --> Terminated; Study subjects were not enrolled. N=346 --> 0 | Recruiting --> Withdrawn
- | Trial completion date, Trial primary completion date: Trial on Vascular Inflammation in Atopic Dermatitis (clinicaltrials.gov) - Mar 15, 2018
P=N/A, N=60, Recruiting, Sponsor: Innovaderm Research Inc.
N=346 --> 0 | Recruiting --> Withdrawn Trial completion date: Aug 2017 --> Aug 2018 | Trial primary completion date: Aug 2017 --> Aug 2018
- | Enrollment closed: ESCORT: Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure (clinicaltrials.gov) - Mar 14, 2018
P1, N=10, Active, not recruiting, Sponsor: Assistance Publique - H
Trial completion date: Aug 2017 --> Aug 2018 | Trial primary completion date: Aug 2017 --> Aug 2018 Recruiting --> Active, not recruiting
- ||| Xience (everolimus-eluting stent) / Abbott
Trial completion: EXPERT CTO: Evaluation of the XIENCE PRIME (clinicaltrials.gov) - Mar 13, 2018
P=N/A, N=250, Completed, Sponsor: Abbott Vascular
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| Trial completion: ISAR2000: Coroflex ISAR 2000 Registry (clinicaltrials.gov) - Mar 13, 2018
P=N/A, N=2877, Completed, Sponsor: B. Braun Melsungen AG
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: LOCOMOTIVE: "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (clinicaltrials.gov) - Mar 13, 2018
P=N/A, N=75, Completed, Sponsor: B. Braun Melsungen AG
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Xience (everolimus-eluting stent) / Abbott
Enrollment open, Trial completion date, Trial primary completion date: A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II (clinicaltrials.gov) - Mar 12, 2018
P=N/A, N=610, Recruiting, Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Trial completion date: Oct 2022 --> Oct 2023 | Trial primary completion date: Oct 2017 --> Oct 2019
- | Trial completion: Improving Intermediate Risk Management. MARK Study (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=2495, Completed, Sponsor: Jordi Gol i Gurina Foundation
Not yet recruiting --> Recruiting | Trial completion date: Oct 2022 --> Oct 2023 | Trial primary completion date: Oct 2017 --> Oct 2019 Active, not recruiting --> Completed
- | Absorb (everolimus-eluting bioresorbable vascular scaffold) / Abbott
Trial suspension: AbsorbISR: Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=53, Suspended, Sponsor: SIS Medical AG
Active, not recruiting --> Completed Terminated --> Suspended
- | sevoflurane / Generic mfg.
Enrollment change, Trial completion date, Trial termination, Trial primary completion date, Surgery: Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=2, Terminated, Sponsor: Triemli Hospital
Terminated --> Suspended N=24 --> 2 | Trial completion date: Sep 2017 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Jul 2017 --> Mar 2018; Very low patient recruitment, changed insurance requirements
- | Trial completion: Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=170, Completed, Sponsor: Seoul National University Hospital
N=24 --> 2 | Trial completion date: Sep 2017 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Jul 2017 --> Mar 2018; Very low patient recruitment, changed insurance requirements Recruiting --> Completed
- | Trial completion, Gene therapy: KAT301: EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease (clinicaltrials.gov) - Mar 8, 2018
P1, N=30, Completed, Sponsor: Kuopio University Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- |||| Trial completion, Trial completion date: DANCE: Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease (clinicaltrials.gov) - Mar 8, 2018
P4, N=285, Completed, Sponsor: Mercator MedSystems, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jan 2018
- | aspirin / Generic mfg.
Trial completion: Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting (clinicaltrials.gov) - Mar 8, 2018
P2/3, N=45, Completed, Sponsor: Karolinska University Hospital
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jan 2018 Active, not recruiting --> Completed
- | Biomarker, Trial completion, Trial completion date: DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes (clinicaltrials.gov) - Mar 8, 2018
P=N/A, N=31, Completed, Sponsor: Mercator MedSystems, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jan 2018
- | Phase classification: VISIBILITY (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=75, Completed, Sponsor: Medtronic Endovascular
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jan 2018 Phase classification: P2/3 --> P=N/A
- | Phase classification: DURABILITY (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=75, Completed, Sponsor: Medtronic Endovascular
Phase classification: P2/3 --> P=N/A Phase classification: P2/3 --> P=N/A
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion date, Trial initiation date, Trial primary completion date, MRI: Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging (clinicaltrials.gov) - Mar 7, 2018
P4, N=40, Recruiting, Sponsor: Timothy M. Bateman
Phase classification: P2/3 --> P=N/A Trial completion date: Feb 2018 --> Mar 2018 | Initiation date: Aug 2014 --> Sep 2014 | Trial primary completion date: Jan 2018 --> Jan 2018
- Trial completion date, Trial primary completion date: Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=19, Recruiting, Sponsor: Lancaster General Hospital
Trial completion date: Feb 2018 --> Mar 2018 | Initiation date: Aug 2014 --> Sep 2014 | Trial primary completion date: Jan 2018 --> Jan 2018 Trial completion date: Apr 2018 --> Aug 2018 | Trial primary completion date: Dec 2017 --> Jul 2018
- |||| Trial completion: Laranjeiras: OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation (clinicaltrials.gov) - Mar 5, 2018
P4, N=60, Completed, Sponsor: Scitech Produtos Medicos Ltda
Trial completion date: Apr 2018 --> Aug 2018 | Trial primary completion date: Dec 2017 --> Jul 2018 Recruiting --> Completed
- || Trial primary completion date: Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=70, Active, not recruiting, Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Recruiting --> Completed Trial primary completion date: Jan 2018 --> Mar 2018
- Enrollment change, Trial termination, Trial primary completion date: ROVER: Registry of the Magellan Robotic System (clinicaltrials.gov) - Mar 1, 2018
P=N/A, N=348, Terminated, Sponsor: Hansen Medical
Trial primary completion date: Jan 2018 --> Mar 2018 N=1000 --> 348 | Recruiting --> Terminated | Trial primary completion date: Nov 2018 --> Aug 2016
- Enrollment change, Trial termination: Embolization Procedures in the Peripheral Vasculature Using the Magellan (clinicaltrials.gov) - Mar 1, 2018
P=N/A, N=15, Terminated, Sponsor: Hansen Medical
N=1000 --> 348 | Recruiting --> Terminated | Trial primary completion date: Nov 2018 --> Aug 2016 N=50 --> 15 | Recruiting --> Terminated